Pacer Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,135
| Closed | -$359K | – | 3744 |
|
|
2024
Q1 | $359K | Sell |
10,135
-88
| -0.9% | -$3.12K | ﹤0.01% | 1676 |
|
|
2023
Q4 | $445K | Buy |
10,223
+4,276
| +72% | +$186K | ﹤0.01% | 1563 |
|
|
2023
Q3 | $227K | Sell |
5,947
-6,553
| -52% | -$250K | ﹤0.01% | 1474 |
|
|
2023
Q2 | $514K | Buy |
+12,500
| New | +$514K | ﹤0.01% | 1467 |
|
|
2023
Q1 | – | Sell |
-13,920
| Closed | -$780K | – | 2282 |
|
|
2022
Q4 | $780K | Buy |
+13,920
| New | +$780K | ﹤0.01% | 976 |
|
|
2022
Q1 | – | Sell |
-7,381
| Closed | -$494K | – | 2405 |
|
|
2021
Q4 | $494K | Buy |
7,381
+90
| +1% | +$6.02K | 0.01% | 1579 |
|
|
2021
Q3 | $499K | Sell |
7,291
-180
| -2% | -$12.3K | 0.01% | 1135 |
|
|
2021
Q2 | $510K | Sell |
7,471
-90
| -1% | -$6.14K | 0.01% | 1128 |
|
|
2021
Q1 | $522K | Sell |
7,561
-289
| -4% | -$20K | 0.01% | 1040 |
|
|
2020
Q4 | $510K | Sell |
7,850
-9,142
| -54% | -$594K | 0.01% | 966 |
|
|
2020
Q3 | $802K | Buy |
+16,992
| New | +$802K | 0.02% | 806 |
|
|
2020
Q1 | – | Sell |
-24,306
| Closed | -$1.42M | – | 879 |
|
|
2019
Q4 | $1.42M | Sell |
24,306
-1,836
| -7% | -$107K | 0.06% | 427 |
|
|
2019
Q3 | $1.57M | Sell |
26,142
-2,007
| -7% | -$121K | 0.04% | 614 |
|
|
2019
Q2 | $1.57M | Buy |
+28,149
| New | +$1.57M | 0.04% | 604 |
|
|
2018
Q4 | – | Sell |
-25,068
| Closed | -$1.65M | – | 775 |
|
|
2018
Q3 | $1.65M | Buy |
25,068
+2,755
| +12% | +$181K | 0.06% | 413 |
|
|
2018
Q2 | $1.44M | Buy |
+22,313
| New | +$1.44M | 0.07% | 438 |
|
|
2017
Q4 | – | Sell |
-7,672
| Closed | -$387K | – | 1234 |
|
|
2017
Q3 | $387K | Buy |
7,672
+1,436
| +23% | +$72.4K | 0.03% | 785 |
|
|
2017
Q2 | $340K | Buy |
6,236
+376
| +6% | +$20.5K | 0.03% | 800 |
|
|
2017
Q1 | $247K | Buy |
5,860
+1,050
| +22% | +$44.3K | 0.03% | 838 |
|
|
2016
Q4 | $206K | Buy |
4,810
+114
| +2% | +$4.88K | 0.03% | 857 |
|
|
2016
Q3 | $194K | Buy |
+4,696
| New | +$194K | 0.03% | 832 |
|